SCHEMBL4378973

SCHEMBL4378973

Cc1cc(O)cc(=O)n1Cc1cccc(F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
LMNA P02545 2/20 0.53
POLB P06746 2/20 0.51
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
GLA P06280 1/20 0.48
IDO1 P14902 2/20 0.46
IDH1 O75874 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2B Q13224 1/20 0.46
CASR P41180 1/20 0.46
GRIA2 P42262 1/20 0.45
PDE1A P54750 7/20 0.44
PDE1B Q01064 7/20 0.44
PDE1C Q14123 7/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4392970 0.83 LMNA (0.60) KDM4EALDH1A1HPGDLMNAPOLB
SCHEMBL4496903 0.81 MIF (0.55) ALDH1A1LMNAPOLBMAPTIDH1
SCHEMBL4379494 0.80 KDM4E (0.58) KDM4EALDH1A1PKMHPGDHSD17B10
SCHEMBL4384316 0.80 LMNA (0.50) KDM4EALDH1A1PKMHPGDHSD17B10
SCHEMBL3520927 0.78 MEN1 (0.50) KDM4EALDH1A1PKMHPGDHSD17B10
SCHEMBL24645041 0.77 POLB (0.59) KDM4EALDH1A1HSD17B10LMNAPOLB
SCHEMBL4376936 0.76 LMNA (0.52) KDM4EALDH1A1PKMLMNAPOLB
SCHEMBL24645139 0.75 POLB (0.56) KDM4EALDH1A1HPGDLMNAPOLB
SCHEMBL24645033 0.75 POLB (0.56) KDM4EALDH1A1HSD17B10LMNAPOLB
SCHEMBL4378877 0.74 MAPK14 (0.49) KDM4EALDH1A1PKMLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070088033-A1 Diaryl Substituted Pyridinones DEVADAS BALEKUDRU 2007-04-19 US claimed
US-20060211694-A1 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PHARMACIA CORPORATION, GLOBAL PATENT DEPARTMENT (US) 2006-09-21 US claimed
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
EP-1490064-B1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE PHARMACIA CORP (US) 2009-11-18 EP disclosed
EP-1490064-B1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE PHARMACIA CORP (US) 2009-11-18 EP disclosed
US-20070088033-A1 Diaryl Substituted Pyridinones DEVADAS BALEKUDRU 2007-04-19 US disclosed
US-20070088033-A1 Diaryl Substituted Pyridinones DEVADAS BALEKUDRU 2007-04-19 US disclosed
US-20070088033-A1 Diaryl Substituted Pyridinones DEVADAS BALEKUDRU 2007-04-19 US disclosed
US-20060211694-A1 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PHARMACIA CORPORATION, GLOBAL PATENT DEPARTMENT (US) 2006-09-21 US disclosed
US-7067540-B2 Substituted pyridinones PHARMACIA CORPORATION (US) 2006-06-27 US disclosed
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
WO-2005018557-A2 SUBSTITUTED PYRIDINONES PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058964-A1 Substituted pyridinones MAPK1, MAPK6, MAPK7 KDM4E 3869/4885ALDH1A1 787/4885PKM 543/4885
US-20060211694-A1 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease LTB4R2, LTB4R, MAPK1 KDM4E 4408/4885ALDH1A1 1030/4885PKM 1683/4885
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 KDM4E 3921/4885ALDH1A1 741/4885PKM 451/4885
US-20070088033-A1 Diaryl Substituted Pyridinones MAPK1, MAPK6, MAP3K6 KDM4E 3570/4885ALDH1A1 1080/4885PKM 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.